• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α4β2*烟碱型乙酰胆碱受体的高亲和力配体6-[18F]氟-A-85380的体外特性研究

In vitro characterization of 6-[18F]fluoro-A-85380, a high-affinity ligand for alpha4beta2* nicotinic acetylcholine receptors.

作者信息

Gündisch Daniela, Koren Andrei O, Horti Andrew G, Pavlova Olga A, Kimes Alane S, Mukhin Alexey G, London Edythe D

机构信息

Neuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, DHHS, Baltimore, Maryland 21224, USA.

出版信息

Synapse. 2005 Feb;55(2):89-97. doi: 10.1002/syn.20096.

DOI:10.1002/syn.20096
PMID:15529332
Abstract

Nicotinic acetylcholine receptors are involved in tobacco dependence and several other neuropathologies (e.g., Alzheimer's disease, Parkinson's disease), as well as in attention, learning, and memory. Performing in vivo imaging of these receptors in humans holds great promise for understanding their role in these conditions. Recently, three radiohalogenated analogs of 3-(2(S)-azetidinylmethoxy)pyridine (A- 85380) were used successfully for the in vivo visualization of alpha4beta2* nicotinic receptors in the human brain with PET/SPECT. Herein, we present the results of the in vitro characterization of one of these radioligands, 6-[18F]fluoro-3-(2(S)-azetidinylmethoxy)-pyridine (6-[18F]fluoro-A-85380), which is a fluoro-analog of the potent nonopioid analgesic ABT-594. In human postmortem cortical tissue, 6-[18F]fluoro-A-85380 reversibly binds with high affinity to a single population of sites (Kd = 59 pM at 37 degrees C, Bmax = 0.7 pmol/g tissue). The binding is fully reversible and is characterized at 37 degrees C by T(1/2assoc) = 2.2 min (at a ligand concentration of 39 pM) and by T(1/2dissoc) = 3.6 min. 6-Fluoro-A-85380 exhibits clear selectivity for alpha4beta2* over the other major mammalian nicotinic receptor subtypes: alpha7, alpha3beta4, and muscle-type. These results suggest that 6-[18F]fluoro-A-85380 is a promising radioligand for in vivo imaging of brain alpha4beta2* nicotinic receptors.

摘要

烟碱型乙酰胆碱受体与烟草依赖及其他几种神经病理学疾病(如阿尔茨海默病、帕金森病)有关,还涉及注意力、学习和记忆。对这些受体进行人体活体成像,对于理解它们在这些病症中的作用具有很大的前景。最近,3-(2(S)-氮杂环丁烷甲氧基)吡啶(A-85380)的三种放射性卤代类似物已成功用于通过正电子发射断层扫描/单光子发射计算机断层扫描对人脑中α4β2烟碱型受体进行活体可视化。在此,我们展示了其中一种放射性配体6-[18F]氟-3-(2(S)-氮杂环丁烷甲氧基)吡啶(6-[18F]氟-A-85380)的体外特性研究结果,它是强效非阿片类镇痛药ABT-594的氟代类似物。在人类死后皮质组织中,6-[18F]氟-A-85380以高亲和力与单一的位点群体可逆性结合(37℃时Kd = 59 pM,Bmax = 0.7 pmol/g组织)。这种结合是完全可逆的,在37℃时,其结合半衰期T(1/2assoc) = 2.2分钟(配体浓度为39 pM时),解离半衰期T(1/2dissoc) = 3.6分钟。6-氟-A-85380对α4β2的选择性明显高于其他主要的哺乳动物烟碱型受体亚型:α7、α3β4和肌肉型。这些结果表明,6-[18F]氟-A-85380是一种有前景的用于脑α4β2*烟碱型受体活体成像的放射性配体。

相似文献

1
In vitro characterization of 6-[18F]fluoro-A-85380, a high-affinity ligand for alpha4beta2* nicotinic acetylcholine receptors.α4β2*烟碱型乙酰胆碱受体的高亲和力配体6-[18F]氟-A-85380的体外特性研究
Synapse. 2005 Feb;55(2):89-97. doi: 10.1002/syn.20096.
2
Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.2-氟-3-[2(S)-2-氮杂环丁烷基甲氧基]吡啶的合成及其在体内对烟碱型乙酰胆碱受体的结合特性:一种用于烟碱型受体的新型正电子发射断层扫描配体。
J Med Chem. 1999 Jun 17;42(12):2251-9. doi: 10.1021/jm9910223.
3
Imaging central nicotinic acetylcholine receptors in baboons with [18F]fluoro-A-85380.用[18F]氟-A-85380对狒狒中枢烟碱型乙酰胆碱受体进行成像。
J Nucl Med. 1999 Aug;40(8):1374-80.
4
Characterization of the nicotinic ligand 2-[18F]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine in vivo.体内烟碱配体2-[18F]氟-3-[2(S)-2-氮杂环丁烷基甲氧基]吡啶的表征。
Life Sci. 1999;64(5):PL93-7. doi: 10.1016/s0024-3205(98)00573-6.
5
Nicotinic α4β2 receptor imaging agents. Part III. Synthesis and biological evaluation of 3-(2-(S)-azetidinylmethoxy)-5-(3'-18F-fluoropropyl)pyridine (18F-nifzetidine).烟碱型乙酰胆碱受体 α4β2 显像剂。第三部分。3-(2-(S)-氮杂环丁烷甲氧基)-5-(3'-18F-丙基)吡啶(18F-尼非佐地定)的合成与生物学评价。
Nucl Med Biol. 2011 Nov;38(8):1183-92. doi: 10.1016/j.nucmedbio.2011.05.005. Epub 2011 Aug 9.
6
5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors.5-碘-A-85380,一种烟碱型乙酰胆碱受体的α4β2亚型选择性配体。
Mol Pharmacol. 2000 Mar;57(3):642-9. doi: 10.1124/mol.57.3.642.
7
Imaging of central nAChReceptors with 2-[18F]F-A85380: optimized synthesis and in vitro evaluation in Alzheimer's disease.用2-[18F]F-A85380对中枢烟碱型乙酰胆碱受体进行成像:阿尔茨海默病中的优化合成及体外评估
Appl Radiat Isot. 2004 Dec;61(6):1235-40. doi: 10.1016/j.apradiso.2004.02.026.
8
NIDA522131, a new radioligand for imaging extrathalamic nicotinic acetylcholine receptors: in vitro and in vivo evaluation.NIDA522131,一种用于成像丘脑外烟碱型乙酰胆碱受体的新型放射性配体:体外和体内评估。
J Neurochem. 2008 Jan;104(2):306-15. doi: 10.1111/j.1471-4159.2007.05009.x. Epub 2007 Nov 6.
9
In vitro evaluation of nicotinic acetylcholine receptors with 2-[18F]F-A85380 in Parkinson's disease.帕金森病中使用2-[18F]F-A85380对烟碱型乙酰胆碱受体进行的体外评估。
Nucl Med Biol. 2006 Apr;33(3):305-9. doi: 10.1016/j.nucmedbio.2005.12.012. Epub 2006 Mar 9.
10
6-[18F]fluoro-A-85380, a novel radioligand for in vivo imaging of central nicotinic acetylcholine receptors.6-[18F]氟-A-85380,一种用于中枢烟碱型乙酰胆碱受体体内成像的新型放射性配体。
Life Sci. 2000 Jun 16;67(4):463-9. doi: 10.1016/s0024-3205(00)00635-4.

引用本文的文献

1
Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging.用于脑成像的可逆结合正电子发射断层显像(PET)放射性配体开发中的注意事项。
Curr Med Chem. 2016;23(18):1818-69. doi: 10.2174/0929867323666160418114826.
2
Abuse liability assessment of tobacco products including potential reduced exposure products.烟草制品(包括潜在减害产品)的滥用倾向评估。
Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3241-62. doi: 10.1158/1055-9965.EPI-09-0948.
3
Development of radioligands with optimized imaging properties for quantification of nicotinic acetylcholine receptors by positron emission tomography.
通过正电子发射断层扫描技术开发具有优化成像特性的放射性配体,用于定量检测烟碱型乙酰胆碱受体。
Life Sci. 2010 Apr 10;86(15-16):575-84. doi: 10.1016/j.lfs.2009.02.029. Epub 2009 Mar 18.
4
Acetylcholine receptors in dementia and mild cognitive impairment.痴呆症和轻度认知障碍中的乙酰胆碱受体
Eur J Nucl Med Mol Imaging. 2008 Mar;35 Suppl 1:S30-45. doi: 10.1007/s00259-007-0701-1.
5
Imaging of cholinergic and monoaminergic neurochemical changes in neurodegenerative disorders.神经退行性疾病中胆碱能和单胺能神经化学变化的成像
Mol Imaging Biol. 2007 Jul-Aug;9(4):243-57. doi: 10.1007/s11307-007-0083-6.
6
Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET.通过正电子发射断层扫描(PET)评估,轻度阿尔茨海默病患者接受卡巴拉汀治疗后脑内11C-尼古丁结合位点的变化。
Psychopharmacology (Berl). 2007 May;191(4):1005-14. doi: 10.1007/s00213-007-0725-z. Epub 2007 Feb 20.
7
A-85380: a pharmacological probe for the preclinical and clinical investigation of the alphabeta neuronal nicotinic acetylcholine receptor.A-85380:一种用于αβ神经元烟碱型乙酰胆碱受体临床前和临床研究的药理学探针。
CNS Drug Rev. 2006 Summer;12(2):100-12. doi: 10.1111/j.1527-3458.2006.00100.x.
8
PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease.皮质11C-尼古丁结合的PET成像与阿尔茨海默病的注意力认知功能相关。
Psychopharmacology (Berl). 2006 Nov;188(4):509-20. doi: 10.1007/s00213-006-0447-7. Epub 2006 Jul 11.
9
The possible contribution of neuronal nicotinic acetylcholine receptors in depression.神经元烟碱型乙酰胆碱受体在抑郁症中的潜在作用。
Dialogues Clin Neurosci. 2005;7(3):207-16. doi: 10.31887/DCNS.2005.7.3/dbertrand.